A worldwide crisis

Alzheimer's disease is predicted to affect 130 million people in the next three decades. Heartbreakingly, as of today, not one drug can prevent, cure or permanently reverse symptoms of Alzheimer’s. Not one.

Its toll is staggering on individuals and their caregivers, destroying personalities, memories and lives. Ending the suffering from Alzheimer’s is what drives our scientists and our entire organization to find treatments and cures for the disease — now.

It's possible…
with your help.

All the pieces are in place. The world is waiting. Will you help speed the discovery of therapies for Alzheimer’s by giving to JAX?

Give Now

Ending Alzheimer's

Imagine stopping Alzheimer’s disease before it erases memories, personalities and lives.

New treatments, applied early to people identified as most vulnerable, could eliminate Alzheimer’s. Genomic technologies have the potential to help stop Alzheimer’s disease before it develops. No one else in the world has the unique advantages of The Jackson Laboratory to do it.

Alzheimer's and Other Dementias

Helix Icon

Give to The Helix Fund

The Helix Fund fuels our scientific research and education. Learn more about the Helix Fund Signature Societies, named after distinguished JAX scientists, and the Catalyst Circle, JAX’s monthly giving society.
Tribute gifts

Make a Tribute Gift

You can commemorate a special occasion and honor someone special by making a gift to JAX in their name.  Learn more

Give to JAX icon

Make a planned gift

You can make a lasting gift through your will or give appreciated stocks, bonds, mutual funds, real estate or other tax beneficial assets. Learn more or contact Laura Eldridge, Director of Major and Planned Gifts.

Microscope

Fund Our Scientists

You can give our scientists needed resources, including endowed chairs, postdoctoral fellowships, and educational opportunities.  Learn more

Learn

Learn about Alzheimers Research at JAX

Genomic technologies have the potential to stop Alzheimer’s disease before it starts and to break the bottleneck of Alzheimer’s drug development. Learn more

Planning icon

Partner With Us: Corporations and Foundations

Contact Peter Lamothe to learn more about opportunities for you to join with JAX to discover treatments and cures.